Prediction of plasma concentration-time curve of orally administered theophylline based on a scintigraphic monitoring of gastrointestinal transit in human volunteers

被引:15
作者
Haruta, S
Kawai, K
Nishii, R
Jinnouchi, S
Ogawara, K
Higaki, K
Tamura, S
Arimori, K
Kimura, T [1 ]
机构
[1] Okayama Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Okayama 7008530, Japan
[2] Miyazaki Med Coll, Dept Hosp Pharm, Miyazaki 8891692, Japan
[3] Miyazaki Med Coll, Cent Res Labs, Miyazaki 8891692, Japan
[4] Miyazaki Med Coll, Dept Radiol, Miyazaki 8891692, Japan
关键词
oral absorption; gastrointestinal transit; gamma scintigraphy; human; GI-transit-absorption model; prediction of absorption profile;
D O I
10.1016/S0378-5173(01)00942-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The plasma concentration time profile of theophylline after oral administration in human volunteers was predicted using the individual gastrointestinal (GI) transit data monitored by a gamma scintigraphic technique. Theophylline was administered as aminophylline under fasted and fed condition, along with Tc-99m-labeled diethylenetriamine-pentaacetic acid (DTPA), an unabsorbable marker to evaluate the GI transit by a gamma scintigraphic technique. Two healthy male volunteers participated under fasted and fed conditions in a crossover study. The GI transit was evaluated by dividing the GI tract to four segments, stomach, jejunum, ileum and cecum/colon. Under the fed condition, the GI transit pattern for each segment was confirmed to alter considerably, causing a delay in the gastric emptying mainly. Further, the plasma concentration curves of theophylline after oral administration were predicted using the GI-Transit-Absorption Model on the basis of individual GI transit parameters calculated by the fitting of the observed data to the GI-Transit Kinetic Model. The absorption rate constant in each segment and the pharmacokinetic parameters after intravenous administration used for the prediction were the values extrapolated from the data in rats and the ones normalized from the values in literatures, respectively. The plasma concentration-time curves for theophylline were well predicted using obtained individual GI transit parameters. The analysis using this method could estimate the variable absorption behavior governed by the GI transit in detail. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:179 / 190
页数:12
相关论文
共 24 条
  • [1] ESTIMATING HUMAN ORAL FRACTION DOSE ABSORBED - A CORRELATION USING RAT INTESTINAL-MEMBRANE PERMEABILITY FOR PASSIVE AND CARRIER-MEDIATED COMPOUNDS
    AMIDON, GL
    SINKO, PJ
    FLEISHER, D
    [J]. PHARMACEUTICAL RESEARCH, 1988, 5 (10) : 651 - 654
  • [2] METHOD FOR MONITORING HARD GELATIN CAPSULE DISINTEGRATION TIMES IN HUMANS USING EXTERNAL SCINTIGRAPHY
    CASEY, DL
    BEIHN, RM
    DIGENIS, GA
    SHAMBHU, MB
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (09) : 1412 - 1413
  • [3] TRANSIT OF PHARMACEUTICAL DOSAGE FORMS THROUGH THE SMALL-INTESTINE
    DAVIS, SS
    HARDY, JG
    FARA, JW
    [J]. GUT, 1986, 27 (08) : 886 - 892
  • [4] DIGENIS GA, 1991, CRIT REV THER DRUG, V7, P309
  • [5] Gamma scintigraphy: an evolving technology in pharmaceutical formulation development - Part 1
    Digenis, GA
    Sandefer, EP
    Page, RC
    Doll, WJ
    [J]. PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1998, 1 (03): : 100 - 107
  • [6] ABSORPTION OF FLURBIPROFEN IN THE FED AND FASTED STATES
    DRESSMAN, JB
    BERARDI, RR
    ELTA, GH
    GRAY, TM
    MONTGOMERY, PA
    LAU, HS
    PELEKOUDAS, KL
    SZPUNAR, GJ
    WAGNER, JG
    [J]. PHARMACEUTICAL RESEARCH, 1992, 9 (07) : 901 - 907
  • [7] GRISEOFULVIN ABSORPTION FROM DIFFERENT SITES IN THE HUMAN SMALL-INTESTINE
    GRAMATTE, T
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 1994, 15 (09) : 747 - 759
  • [8] GI TRANSIT OF POTENTIAL BIOADHESIVE FORMULATIONS IN MAN - A SCINTIGRAPHIC STUDY
    HARRIS, D
    FELL, JT
    SHARMA, HL
    TAYLOR, DC
    [J]. JOURNAL OF CONTROLLED RELEASE, 1990, 12 (01) : 45 - 53
  • [9] Absorption behavior of orally administered drugs in rats treated with propantheline
    Haruta, S
    Iwasaki, N
    Ogawara, K
    Higaki, K
    Kimura, T
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (09) : 1081 - 1085
  • [10] Haruta S, 2001, J PHARM SCI, V90, P464, DOI 10.1002/1520-6017(200104)90:4<464::AID-JPS1004>3.0.CO